The effects of antipsychotic quality reporting on antipsychotic and psychoactive medication use

Health Services Research

Volumn 50, Issue 4, 2015, Pages 1069-1087

  Bowblis, John R ^a   Lucas, Judith A ^b   Brunt, Christopher S ^c  

^a MIAMI UNIVERSITY   (United States)

^b SETON HALL UNIVERSITY   (United States)

^c GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

antipsychotics; Nursing home compare; psychoactive medications; public reporting; quality

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CONTROLLED STUDY; DEMENTIA; DETERIORATION; DRUG USE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; NURSING HOME; PERSONAL EXPERIENCE; PUBLIC REPORTING; QUALITY OF LIFE; CLINICAL PRACTICE; DRUG UTILIZATION; HOME FOR THE AGED; STATISTICS AND NUMERICAL DATA;

ANTIPSYCHOTIC AGENTS; DRUG UTILIZATION; HOMES FOR THE AGED; HUMANS; HYPNOTICS AND SEDATIVES; NURSING HOMES; PRACTICE PATTERNS, PHYSICIANS'; PSYCHOTROPIC DRUGS; QUALITY OF HEALTH CARE;

EID: 84937968368     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12281     Document Type: Article

References (37)

1. American Geriatrics Society. 2012. " AGS Guide to the Management of Psychotic Disorders and Neuropsychiatric Symptoms of Dementia in Older Adults " [accessed on February 15, 2014]. Available at http://dementia.americangeriatrics.org/GeriPsych-index.php
2. Azermai, M., M. Petrovic, S. Engelborghs, M. M. Elseviers, S. Van der Mussele, H. Debruyne, L. Van Bortel, and, R. H. Vander Stichele,. 2013. " The Effects of Abrupt Antipsychotic Discontinuation in Cognitively Impaired Older Persons: A Pilot Study." Aging & Mental Health 17 (1): 125-32.
3. Baker, G., 2002. " Distortion and Risk in Optimal Incentive Contracts." Journal of Human Resources 37 (4): 728-51.
4. Bowblis, J. R., and, J. A. Lucas,. 2012. " The Impact of State Regulations on Nursing Home Care Practices." Journal of Regulatory Economics 42: 52-72.
5. Bowblis, J. R., S. Crystal, O. Intrator, and, J. A. Lucas,. 2012. " Response to Regulatory Stringency: The Case of Antipsychotic Medication Use in Nursing Homes." Health Economics 21: 977-93.
6. Briesacher, B. A., M. R. Limcangco, L. Simoni-Wastila, J. A. Doshi, S. R. Levens, D. G. Shea, and, B. Stuart,. 2005. " The Quality of Antipsychotic Drug Prescribing in Nursing Homes." Archives of Internal Medicine 165: 1280-5.
7. Centers for Medicare and Medicaid Services [CMS]. 2006. Interpretive Guidelines for Long-Term Facilities, Appendix PP-Guidance to Surveyors for Long-Term Care Facilities. In: State Operations Manual. Baltimore, MD: CMS.
8. Centers for Medicare and Medicaid Services [CMS]. 2012. " Description of Antipsychotic Medication Quality Measures on Nursing Home Compare " [accessed on July 15, 2012]. Available at https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/Downloads/AntipsychoticMedicationQM.pdf
9. Centers for Medicare & Medicaid Services [CMS]. 2013. " Advanced Copy: Dementia Care In Nursing Homes: Clarification to Appendix P State Operations Manual (SOM) and Appendix PP in SOM for F309-Quality of Care and F329-Unnecessary Drugs " [accessed on February 15, 2014]. Available at http://www.Cms.gov/Medicare/Provider-Enrollment-and-Certification/Survey-CertificationGenInfo/Downloads/Survey-and-Cert-Letter-13-35.pdf
10. CMS Press Release. 2012. " CMS Announces Partnership to Improve Dementia Care. " [accessed on May 30, 2012]. Available at http://www.CMS.gov
11. Feng, Z., P. R. Katz, O. Intrator, J. Karuza, and, V. Mor,. 2005. " Physician and Nurse Staffing in Nursing Homes: The Role and Limitations of the Online Survey Certification and Reporting (OSCAR) System." Journal of the American Medical Directors Association 6: 27-33.
12. Glickman, S. W., F. Ou, E. R. DeLong, M. T. Roe, B. L. Lytle, J. Mulgund, J. S. Rumsfeld, W. B. Gibler, E. M. Ohman, K. A. Schulman, and, E. D. Peterson,. 2007. " Pay for Performance, Quality of Care, and Outcomes in Acute Myocardial Infarction." Journal of the American Medical Association 297 (21): 2373-80.
13. Gordon, M., 2014. " When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia Be Discontinued? " Annals of Long Term Care: Clinical Care and Aging 22 (4): 24-9.
14. Grabowski, D. C., and, R. J. Town,. 2011. " Does Information Matter? Competition, Quality and the Impact of Nursing Home Report Cards." Health Services Research 46 (6 Pt 1): 1698-719.
15. Hughes, C. M., and, K. L. Lapane,. 2005. " Administrative Initiatives for Reducing Inappropriate Prescribing of Psychotropic Drugs in Nursing Homes: How Successful Have They Been? " Drugs and Aging 22 (4): 339-51.
16. Hughes, C., K. Lapane, and, V. Mor,. 1999. " Impact of Legislation on Nursing Home Care in the United States: Lessons for the United Kingdom." British Medical Journal 319 (7216): 1060-2.
17. Huybrechts, K. F., S. Schneeweiss, T. Gerhard, M. Olfson, J. Avorn, R. Levin, J. A. Lucas, and, S. Crystal,. 2012. " Comparative Safety of Antipsychotic Medications in Nursing Home Residents." Journal of the American Geriatric Society 60 (3): 420-9.
18. Kales, H. C., K. Zivin, H. M. Kim, M. Valenstein, C. Chiang, R. V. Ignacio, D. Ganoczy, F. Cunningham, L. S. Schneider, and, F. C. Blow,. 2011. " Trends in Antipsychotic Use in Dementia 1999-2007." Archives of General Psychiatry 68 (2): 190-8.
19. Konetzka, R. T., D. J. Brauner, J. Shega, and, R. M. Werner,. 2014. " The Effects of Public Reporting on Physical Restraints and Antipsychotic Use in Nursing Home Residents with Severe Cognitive Impairment." Journal of the American Geriatrics Society 62 (3): 454-61.
20. Lau, D. T., J. D. Kasper, D. E. B. Potter, and, A. Lyles,. 2004. " Potentially Inappropriate Medication Prescriptions among Elderly Nursing Home Residents: Their Scope and Associated Resident and Family Characteristics." Health Services Research 39 (5): 1257-76.
21. Lindenauer, P. K., D. Remus, S. Roman, M. B. Rothberg, E. M. Benjamin, A. Ma, and, D. W. Bratzler,. 2007. " Public Reporting and Pay for Performance in Hospital Quality Improvement." New England Journal of Medicine 356 (5): 486-96.
22. Liperoti, R., V. Mor, K. L. Lapane, C. Pedone, G. Gambassi, and, R. Benabei,. 2003. " The Use of Atypical Antipsychotics in Nursing Homes." Journal of Clinical Psychiatry 64 (9): 1106-12.
23. Lu, S. F., 2012. " Multitasking, Information Disclosure, and Product Quality: Evidence from Nursing Homes." Journal of Economics and Management Strategy 21 (3): 673-705.
24. Lucas, J. A., S. Chakravarty, J. R. Bowblis, T. Gerhard, E. Kalay, E. K. Paek, and, S. Crystal,. 2014. " Antipsychotic Medication Use in Nursing Homes: A Proposed Measure of Quality." International Journal of Geriatric Psychiatry 29 (10): 1049-61. doi: 10.1002/gps.4098.
25. McKie, J. W., 1970. " Regulation and the Free Market: The Problem of Boundaries." Bell Journal of Economics and Management Science 1 (1): 6-26.
26. Mukamel, D. B., W. D. Spector, J. S. Zinn, L. Huang, D. L. Weimer, and, A. Dozier,. 2007. " Nursing Homes' Response to the Nursing Home Compare Report Card." Journal of Gerontology: Social Sciences 62 (4): S218-25.
27. Mukamel, D. B., D. L. Weimer, W. D. Spector, H. Ladd, and, J. S. Zinn,. 2008. " Publication of Quality Report Cards and Trends in Reported Quality Measures in Nursing Homes." Health Services Research 43 (4): 1244-62.
28. Office of Inspector General [OIG]. 2011. " Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents " [accessed on March 1, 2014]. Available at https://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf
29. Ray, W. A., C. P. Chung, K. T. Murray, et al., 2009. " Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death." New England Journal of Medicine 360: 225-35.
30. Rochon, P., S. Normand, T. Gomes, et al., 2008. " Antipsychotic Therapy and Short-Term Serious Events in Older Adults with Dementia." Archives of Internal Medicine 168: 1090-6.
31. Schneider, L., K. Dagerman, and, P. Insel,. 2005. " Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia: Meta-Analysis of Randomized Placebo-Controlled Trials." Journal of the American Medical Association 294 (15): 1934-43.
32. Schneider, L., K. Dagerman, and, P. S. Insel,. 2006b. " Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-Analysis of Randomized, Placebo-Controlled Trials." American Journal of Geriatric Psychiatry 14: 191-210.
33. Schneider, L., P. Tariot, and, K. Dagerman,. 2006a. " Effectiveness of Atypical Antipsychotic Drugs in Residents with Alzheimer's Disease." New England Journal of Medicine 355: 1525-38.
34. Simoni-Wastila, L., Y. Wei, M. Luong, C., Franey, T., Huang, G. B. Rattinger, I. H. Zuckerman, N. Brandt, and, J. A. Lucas,. 2014. " Quality of Psychopharmacological Medication Use in Nursing Home Residents." Research in Social and Administrative Pharmacy 10 (3): 494-507.
35. Stevenson, D. G., 2006. " Is a Public Reporting Approach Appropriate for Nursing Home Care? " Journal of Health Politics, Policy and Law 31 (4): 773-810.
36. Werner, R. M., R. T. Konetzka, E. A. Stuart, E. C. Norton, D. Polsky, and, J. Park,. 2009. " Impact of Public Reporting on Quality of Postacute Care." Health Services Research 44 (4): 1169-87.
37. Werner, R. M., E. C. Norton, R. T. Konetzka, and, D. Polsky,. 2012. " Do Consumers Respond to Publically Reported Quality Information? Evidence from Nursing Homes." Journal of Health Economics 31: 50-61.